Page 334 - Demo
P. 334


                                    Addendum332N-of-1 studies: Methylphenidate for behavioral problems in phenylketonuriaAmsterdam Public Health, webinar2022 0.5TSC-PROM development and validation TSC-Associated Neuropsychiatric Disorders symposium, virtual2022 0.5Trial designs for rare diseasesEuropean Reference Network (ERN-ITHACA), Budapest, Hungary2022 0.5Implementation of genetic diagnoses in ID careAmsterdam Kindersymposium, Amsterdam2023 0.5Cannabidiol for complex behavior in FXSFragiele X expertisenetwerk, virtual2023 0.5N-of-1 studies: Research or clinical practice?Amsterdam Public Health Special, Amsterdam2023 0.5De toegevoegde waarde van een genetische diagnoseZonMW conference ‘Zorg voor mensen met een VB’, Amersfoort2023 0.5Development and validation of the TSC-PROMTSC-Associated Neuropsychiatric Disorders symposium, virtual2023 0.5Development and validation of the TSC-PROMInternational TSC conference, Washington D.C., USA2023 0.5PosterThe power of 1: N-of-1 studies to improve interventional research for Tuberous Sclerosis ComplexInternational TSC conference, virtual2021 0.5The power of 1: Systematic review and a study protocol for N-of-1 studies in rare genetic neurodevelopmental disordersSociety for the Study of Behavioural Phenotypes (SSBP) research symposium, virtual2021 0.5Can we make personalized care for individuals with ID happen? Insights from a large ID registrySSBP research symposium, Oslo, Norway2022 0.5ICT4RARE: Personalized care for individuals with IDAmsterdam Public Health Annual meeting, Amsterdam2022 0.5Cannabidiol for severe behavioral manifestations in RGNDs; implementation of genetic diagnoses in multidisciplinary ID care (2)European Reference Network (ERN-ITHACA), Hoofddorp2023 0.5Cannabidiol for severe behavioral manifestations in RGNDsInternational TSC conference, Washington D.C., USA2023 0.5(Inter)national conferencesJonge Onderzoeksdag Erfelijke Aangeboren Aandoeningen, Maastricht 2019 0.3Amsterdam Kindersymposium, Amsterdam 2020 0.3Amsterdam Neuroscience Annual Meeting, virtual 2020 0.3Annelieke Muller sHL.indd 332 14-11-2023 09:08
                                
   328   329   330   331   332   333   334   335   336   337   338